Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ultragenyx Pharmaceutical...

    NASDAQ: RARE · Real-Time Price · USD
    29.68
    0.67 (2.31%)
    At close: Aug 15, 2025, 3:59 PM
    29.87
    0.62%
    After-hours: Aug 15, 2025, 07:57 PM EDT

    Ultragenyx Pharmaceutical Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -569.18M -606.64M -707.42M -454.02M
    Depreciation & Amortization
    		 35.54M 26.01M 18.22M 13.24M
    Stock-Based Compensation
    		 158.03M 135.21M 130.38M 104.95M
    Other Working Capital
    		 11.73M 12.23M -5.44M -57.49M
    Other Non-Cash Items
    		 -52.5M -12.67M 119.76M 11.71M
    Deferred Income Tax
    		 n/a -1.62M -1.64M 48.67M
    Change in Working Capital
    		 13.92M -15.1M 60.23M -63.24M
    Operating Cash Flow
    		 -414.19M -474.81M -380.46M -338.69M
    Capital Expenditures
    		 -7.49M -46.77M -146.12M -73.09M
    Cash Acquisitions
    		 n/a n/a -75.03M n/a
    Purchase of Investments
    		 -408.61M -526.38M -614.74M -1.01B
    Sales Maturities Of Investments
    		 413.27M 746.2M 545.08M 890.85M
    Other Investing Acitivies
    		 -14.94M -7.55M -844K -942K
    Investing Cash Flow
    		 -17.77M 168M -291.65M -195.37M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 18.26M 8.39M 501.21M 39.61M
    Financial Cash Flow
    		 399.24M 388.14M 501.21M 118.55M
    Net Cash Flow
    		 -35.24M 81.8M -171.98M -416.71M
    Free Cash Flow
    		 -421.68M -521.57M -526.59M -411.79M

    Add to Watchlist